{
  "entities": [
    "2022-03",
    "2022-08",
    "2022-10-15",
    "2022-Q2",
    "2023-07",
    "2023-11-15",
    "2023-11-20",
    "2023-12-01",
    "2024-02",
    "2254 Willow Lane",
    "47823-9K",
    "50+",
    "58",
    "6-week",
    "CM-8871",
    "Fabrizio Wasicki",
    "MetroCare diabetes study",
    "PX-908712",
    "Polk Health Network",
    "Rivertown Clinic",
    "Silver Pine Clinic",
    "antibody deficiency",
    "autoimmune responses",
    "gene therapy",
    "hyper-inflammatory reactions",
    "neuropathy",
    "targeted immunotherapy",
    "type 2 diabetes"
  ],
  "links": [
    [
      "cluster_0_doc1",
      "cluster_0_doc3",
      "cluster_0_doc4"
    ],
    [
      "cluster_1_doc2",
      "cluster_1_doc4"
    ],
    [
      "cluster_1_doc2",
      "cluster_1_doc5"
    ],
    [
      "cluster_2_doc1",
      "cluster_2_doc2"
    ],
    [
      "cluster_2_doc1",
      "cluster_2_doc3"
    ]
  ],
  "redaction": [
    {
      "cluster_id": [
        "Fabrizio Wasicki",
        "PX-908712",
        "2023-11-15",
        "2023-12-01",
        "2023-11-20",
        "Polk Health Network",
        "50+"
      ]
    },
    {
      "cluster_id": [
        "58",
        "2023-07",
        "MetroCare diabetes study"
      ]
    },
    {
      "cluster_2": [
        "47823-9K",
        "2254 Willow Lane",
        "6-week"
      ]
    }
  ]
}